Medtronic (NYSE:MDT) announced today that it received FDA clearance for its Stealth AXiS robotic system for spine surgery.

The Stealth AXiS system architecture allows support for a variety of surgeon preferences and clinical complexities.

Medtronic (NYSE:MDT) plans to spin off its Diabetes segment through an IPO of its subsidiary MiniMed Group, creating a ...

CEO Geoff Martha said that while Hugo may not “move the needle” for Medtronic’s surgical business yet, the system is growing ...

Medtronic is investing in the rollout of the Symplicity Spyral renal denervation procedure, including hiring for new market ...

Medtronic (NYSE:MDT) continues to lead in medical technology, making significant contributions to the S&P 500 Chart ...

MINNEAPOLIS — Seventy-five years ago, Medtronic, the world’s largest medical device company, was born. It was created in a garage in Minneapolis by two men who would go on to invent the pacemaker.

DUBLIN and CHENNAI, India, Sept. 27, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT) and Apollo Hospitals Group today announced the first clinical procedure in Asia-Pacific with the Hugo™ ...

DUBLIN, Nov. 15, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...